Industrial Machinery & Robotics Global On demand · 24-48h

Global Industrial Fermentation Tank Market Strategic Research Report

Global Industrial Fermentation Tank Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Industrial Fermentation Tank Market
$1.51B2025
7.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Batch Fermentation Tank, Fed-Batch Fermentation Tank, Continuous Fermentation Tank

By Application: Enzyme Production, Organic Acid Production, Microbial Culture, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Sartorius AG, Getinge AB (Applikon Biotechnology), Thermo Fisher Scientific Inc., Eppendorf SE, GEA Group AG, Alfa Laval AB, ZETA GmbH, Pierre Guérin SAS, ABEC, Inc., Bioengineering AG, Bionet Co., Ltd., Donaldson Company, Inc. (Solaris Biotech), Infors HT, Marubishi Bioengineering Co., Ltd., Morimatsu International Holdings Company Limited, Shanghai Tofflon Science and Technology Co., Ltd., Zhejiang Tailin Bioengineering Co., Ltd., Shanghai Bailun Biotechnology Co., Ltd., Shanghai Baoxing Bioengineering Equipment Co., Ltd., Jiangsu Lianzhong Equipment Technology Co., Ltd., Wuxi Zhanghua Pharmaceutical Equipment Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 156 pages
Market size 2025
$1.51B
Billion USD
Forecast CAGR
7.3%
2025-2032
Forecast 2032
$2.5B
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Industrial Fermentation Tank market size is predicted to grow from US$ 1,507 million in 2025 to US$ 2,473 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.

In 2025, global Industrial Fermentation Tank production reached approximately 22,647 units, with an average global market price of around USD 68,000 per unit.

The gross profit margin of major companies in the industry is between 24%–36%.

In 2025, the global production capacity of Industrial Fermentation Tank was approximately 30,000 units.

Industrial Fermentation Tank is a process vessel designed to cultivate microorganisms or cells under controlled conditions for large-scale industrial production. The equipment provides precise control of temperature, pressure, pH, dissolved oxygen, agitation, and sterilization to ensure stable biological reactions and high product yield. It is widely used in biopharmaceuticals, food and beverage, industrial biotechnology, enzyme production, amino acids, organic acids, and fermentation-based chemicals. The product boundary includes stainless steel fermentation tanks with integrated control systems, excluding laboratory fermenters and downstream purification equipment.

The industrial fermentation tank industry chain includes upstream suppliers of stainless steel, valves, pumps, sensors, agitators, heat exchangers, automation components, and control systems; the midstream sector covers vessel design, fabrication, welding, polishing, assembly, validation, and commissioning; the downstream sector includes biopharmaceutical manufacturing, food fermentation, beverage production, industrial biotechnology, chemical processing, and bio-based materials. Market growth is driven by increasing demand for biomanufacturing, fermentation-derived products, and sustainable industrial production technologies.

Global key Industrial Fermentation Tank players cover Sartorius AG, Getinge AB (Applikon Biotechnology), Thermo Fisher Scientific Inc., Eppendorf SE, GEA Group AG, etc.

Report Scope

Key Questions Addressed in this Report

What is the 10-year outlook for the global Industrial Fermentation Tank market?

What factors are driving Industrial Fermentation Tank market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Industrial Fermentation Tank market opportunities vary by end market size?

How does Industrial Fermentation Tank break out by Type, by Application?

This report presents a comprehensive overview of the global Industrial Fermentation Tank market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Batch Fermentation Tank
  • Fed-Batch Fermentation Tank
  • Continuous Fermentation Tank

Segment by Tank Configuration

  • Stirred Tank Fermenter
  • Airlift Fermenter
  • Bubble Column Fermenter

Segment by Working Volume

  • Small Volume (<1,000 L)
  • Medium Volume (1,000–20,000 L)
  • Large Volume (>20,000 L)

Segment by Application

  • Enzyme Production
  • Organic Acid Production
  • Microbial Culture
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Industrial Fermentation Tank market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Enzyme Production, Organic Acid Production, Microbial Culture evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Industrial Fermentation Tank Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.51B
2025
Forecast
$2.5B
2032
CAGR
7.3%
2025–2032
区域
5
global
Key companies
Sartorius AGGetinge AB (Applikon Biotechnology)Thermo Fisher Scientific Inc.Eppendorf SEGEA Group AGAlfa Laval ABZETA GmbHPierre Guérin SAS
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Batch Fermentation TankFed-Batch Fermentation TankContinuous Fermentation Tank
By Application
Enzyme ProductionOrganic Acid ProductionMicrobial CultureOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Batch Fermentation Tank
  • 3.1.3 Fed-Batch Fermentation Tank
  • 3.1.4 Continuous Fermentation Tank
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Enzyme Production
  • 4.1.3 Organic Acid Production
  • 4.1.4 Microbial Culture
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Sartorius AG
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Getinge AB (Applikon Biotechnology)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Thermo Fisher Scientific Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Eppendorf SE
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 GEA Group AG
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Alfa Laval AB
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 ZETA GmbH
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Pierre Guérin SAS
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 ABEC, Inc.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Bioengineering AG
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Bionet Co., Ltd.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Donaldson Company, Inc. (Solaris Biotech)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Infors HT
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Marubishi Bioengineering Co., Ltd.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Morimatsu International Holdings Company Limited
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Shanghai Tofflon Science and Technology Co., Ltd.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Zhejiang Tailin Bioengineering Co., Ltd.
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Shanghai Bailun Biotechnology Co., Ltd.
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Shanghai Baoxing Bioengineering Equipment Co., Ltd.
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Jiangsu Lianzhong Equipment Technology Co., Ltd.
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Wuxi Zhanghua Pharmaceutical Equipment Co., Ltd.
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Industrial Fermentation Tank market?
The global Industrial Fermentation Tank market is estimated at US$ 1.51 billion in 2025 (base year) and is projected to reach US$ 2.47 billion by 2032.
What is the forecast CAGR for the Industrial Fermentation Tank market?
The market is expected to grow at a CAGR of 7.3% from 2026 to 2032, expanding from US$ 1.51 billion in 2025 to US$ 2.47 billion in 2032, roughly 1.6 times its base-year value.
What is Industrial Fermentation Tank?
In 2025, global Industrial Fermentation Tank production reached approximately 22,647 units, with an average global market price of around USD 68,000 per unit.
How is the Industrial Fermentation Tank market segmented by type?
By type, the market is segmented into Batch Fermentation Tank, Fed-Batch Fermentation Tank and Continuous Fermentation Tank.
What are the key applications of Industrial Fermentation Tank?
Key applications covered include Enzyme Production, Organic Acid Production, Microbial Culture and Other.
Which companies are profiled in the Industrial Fermentation Tank market report?
Key players profiled include Sartorius AG, Getinge AB (Applikon Biotechnology), Thermo Fisher Scientific Inc., Eppendorf SE, GEA Group AG, Alfa Laval AB, ZETA GmbH and Pierre Guérin SAS, among 21 companies covered in total.
What geographies does the Industrial Fermentation Tank market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Industrial Fermentation Tank?
Market growth is driven by increasing demand for biomanufacturing, fermentation-derived products, and sustainable industrial production technologies.
Who should buy the Industrial Fermentation Tank market report?
The report is intended for manufacturers and solution providers, distributors and end users in Enzyme Production, Organic Acid Production and Microbial Culture, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Industrial Fermentation Tank market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.